Huntington's disease, with its dominant loss of striatal neurons, is triggered by an expanded glutamine tract in huntingtin. To investigate a proposed role for increased activation of the apoptotic cascade in mutant huntingtin's trigger mechanism, we examined huntingtin cleavage and lesion severity after mild ischemic injury in Hdh Q92 mice. We found activation of calpain and caspase proteases and proteolysis of huntingtin in lesioned striatum. However, huntingtin fragments resembled products of calpain I, not caspase-3, cleavage and turnover was accompanied by augmented levels of full-length normal and mutant protein. By contrast, the number of apoptotic cells, total and striatal infarct size, and degree of neurologic deficit were similar in Hdh Q92 and wild-type mice, indicating that the disease process neither strongly protected nor sensitized striatal neurons to apoptotic death. Thus, our findings do not support a role for increased apoptosis or caspase-3 cleavage in the mechanism by which mutant huntingtin triggers disease. However, they suggest that calpain activation and huntingtin regulation merit investigation as modifiers of disease progression in neurons injured by the harmful consequences of full-length mutant huntingtin.
INTRODUCTION
Huntington's disease (HD) is a dominant neurodegenerative disorder caused by HD CAG repeats that elongate an amino-terminal glutamine segment in huntingtin (Huntington's Disease Collaborative Research Group, 1993). Huntingtin's intrinsic function is not known, although it may act as a flexible scaffold for RNA-protein complexes in the cytoplasm and the nucleus (Boutell et al., 1999; Trettel et al., 2000; Hilditch-Maguire et al., 2000) . Genetic studies in HD patients have shown that the mechanism by which mutant huntingtin triggers the disease process is striatal-specific, progressive with polyglutamine length, and dominant over the normal protein. By contrast, after it has been initiated, disease progression is not correlated with HD CAG size and, therefore, must be determined by factors other than mutant huntingtin (Gusella & MacDonald, 2000) .
A popular hypothesis for the HD trigger mechanism assumes increased activation of apoptosis, in the absence of neuronal cell death, as proposed for Alzheimer's disease (Roth, 2001) . In particular, site-specific mutant huntingtin cleavage by caspase-3 (Goldberg et al., 1996) has been hypothesized to yield a "toxic"
